| For: | Cheng MR, Li Q, Wan T, He B, Han J, Chen HX, Yang FX, Wang W, Xu HZ, Ye T, Zha BB. Galactosylated chitosan/5-fluorouracil nanoparticles inhibit mouse hepatic cancer growth and its side effects. World J Gastroenterol 2012; 18(42): 6076-6087 [PMID: 23155336 DOI: 10.3748/wjg.v18.i42.6076] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i42/6076.htm |
| Number | Citing Articles |
| 1 |
Javid Sadri Nahand, Arash Salmaninejad, Samaneh Mollazadeh, Seyed Saeed Tamehri Zadeh, Mehdi Rezaee, Amir Hossein Sheida, Fatemeh Sadoughi, Parisa Maleki Dana, Mahdi Rafiyan, Masoud Zamani, Seyed Pouya Taghavi, Fatemeh Dashti, Seyed Mohammad Ali Mirazimi, Hossein Bannazadeh Baghi, Mohsen Moghoofei, Mohammad Karimzadeh, Massoud Vosough, Hamed Mirzaei. Cell Biology and Translational Medicine, Volume 17. Advances in Experimental Medicine and Biology 2022; 1401 doi: 10.1007/5584_2022_715
|
| 2 |
Tenzin Tsering Dongsar, Tenzin Sonam Dongsar, Neelima Gupta, Waleed H. Almalki, Amirhossein Sahebkar, Prashant Kesharwani. Emerging potential of 5-Fluorouracil-loaded chitosan nanoparticles in cancer therapy. Journal of Drug Delivery Science and Technology 2023; 82 doi: 10.1016/j.jddst.2023.104371
|
| 3 |
Xier Pan, Shuting Ni, Kaili Hu. Nanomedicines for reversing immunosuppressive microenvironment of hepatocellular carcinoma. Biomaterials 2024; 306 doi: 10.1016/j.biomaterials.2024.122481
|
| 4 |
Mohamed Nasr, Mohamed K. Ghorab, Ahmed Abdelazem. In vitro and in vivo evaluation of cubosomes containing 5-fluorouracil for liver targeting. Acta Pharmaceutica Sinica B 2015; 5(1) doi: 10.1016/j.apsb.2014.12.001
|
| 5 |
Lanxia Liu, Hai Wang, Qi Liu, Mingli Duan, Xia Dong, Dunwan Zhu, Yingjun Zhu, Xigang Leng. Biodistribution of TAT‐LHRH conjugated chitosan/DNA nanoparticles in the mice bearing hepatoma xenografts. Journal of Biomedical Materials Research Part A 2016; 104(10) doi: 10.1002/jbm.a.35775
|
| 6 |
Sharon M. Sagnella, Joshua A. McCarroll, Maria Kavallaris. Drug delivery: Beyond active tumour targeting. Nanomedicine: Nanotechnology, Biology and Medicine 2014; 10(6) doi: 10.1016/j.nano.2014.04.012
|
| 7 |
Rongrong Zhu, Xianzheng Wu, Yu Xiao, Bo Gao, Qian Xie, Hui Liu, Shilong Wang. Synergetic Effect of SLN-Curcumin and LDH-5-Fu on SMMC-7721 Liver Cancer Cell Line. Cancer Biotherapy and Radiopharmaceuticals 2013; 28(8) doi: 10.1089/cbr.2012.1445
|
| 8 |
Hassaan Umar, Habibah A. Wahab, Amirah Mohd Gazzali, Hafsa Tahir, Waqas Ahmad. Cubosomes: Design, Development, and Tumor-Targeted Drug Delivery Applications. Polymers 2022; 14(15) doi: 10.3390/polym14153118
|
| 9 |
Aynaz Mazandarani, Ali Taravati, Javad Mohammadnejad, Fatemeh Yazdian. Targeted Anticancer Drug Delivery Using Chitosan, Carbon Quantum Dots, and Aptamers to Deliver Ganoderic Acid and 5‐Fluorouracil. Chemistry & Biodiversity 2023; 20(9) doi: 10.1002/cbdv.202300659
|
| 10 |
Yinghua Wu, Junfeng Zhang, Wen He, Chenchen Li, Yanli Wang. Nanomaterials for Targeting Liver Disease: Research Progress and Future Perspectives. Nano Biomedicine and Engineering 2023; 15(2) doi: 10.26599/NBE.2023.9290024
|
| 11 |
Sujan Chatterjee, Debajyoti Patra, Udipta Chakraborti, Dipanwita Sengupta, Pujita Ghosh, Anupam Basu, Gobinda Chandra Sadhukhan, Kaustav Dutta Chowdhury. Association of p38MAPK‐p53‐Fas aggregation in S‐allyl cysteine mediated regulation of hepatocarcinoma. Environmental Toxicology 2019; 34(8) doi: 10.1002/tox.22764
|
| 12 |
Seyed Mohammad Ali Mirazimi, Fatemeh Dashti, Mohammad Tobeiha, Ali Shahini, Raha Jafari, Mehrad Khoddami, Amir Hossein Sheida, Parastoo EsnaAshari, Amir Hossein Aflatoonian, Fateme Elikaii, Melika Sadat Zakeri, Michael R Hamblin, Mohammad Aghajani, Minoodokht Bavarsadkarimi, Hamed Mirzaei. Application of Quercetin in the Treatment of Gastrointestinal Cancers. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.860209
|
| 13 |
Xiaoxuan Liu, Lin Zhu, Jingjing Ma, Xinxiao Qiao, Dunwan Zhu, Lanxia Liu, Xigang Leng. Target-specific delivery of siRNA into hepatoma cells’ cytoplasm by bifunctional carrier peptide. Drug Delivery and Translational Research 2017; 7(1) doi: 10.1007/s13346-016-0348-1
|
| 14 |
Ahmed Y. Kira, Amir Mohamed Abdelhamid, Mohamed Nasr. Navigating liver targeting: Fine-tuning chitosan nanocarriers through saccharide modification. Journal of Drug Delivery Science and Technology 2024; 95 doi: 10.1016/j.jddst.2024.105644
|
| 15 |
Prashant Kesharwani, Kratika Halwai, Saurav Kumar Jha, Mohammed H. AL Mughram, Salem Salman Almujri, Waleed H. Almalki, Amirhossein Sahebkar. Folate-engineered chitosan nanoparticles: next-generation anticancer nanocarriers. Molecular Cancer 2024; 23(1) doi: 10.1186/s12943-024-02163-z
|
| 16 |
Maria Cristina Bonferoni, Elisabetta Gavini, Giovanna Rassu, Marcello Maestri, Paolo Giunchedi. Chitosan Nanoparticles for Therapy and Theranostics of Hepatocellular Carcinoma (HCC) and Liver-Targeting. Nanomaterials 2020; 10(5) doi: 10.3390/nano10050870
|
| 17 |
Jeferson Gustavo Henn, Tanira Alessandra Silveira Aguirre, Michael Nugent, Dinara Jaqueline Moura. Cancer nanomedicine: Recent developments in drug delivery systems and strategies to overcome eventual barriers to achieve a better outcome. Journal of Drug Delivery Science and Technology 2024; 91 doi: 10.1016/j.jddst.2023.105254
|
| 18 |
Tian Yunan, Xiang Yuke, Wan Guoran, Wan Dong, Zhu Huifeng, Wang Tao, Yang Xian. Effects and mechanisms of Bazhen decoction, Siwu decoction, and Sijunzi decoction on 5-fluorouracil-induced anemia in mice. Journal of Traditional Chinese Medicine 2016; 36(4) doi: 10.1016/S0254-6272(16)30066-8
|
| 19 |
Badriya Baig, Sulafa Abdel Halim, Aaminah Farrukh, Yaser Greish, Amr Amin. Current status of nanomaterial-based treatment for hepatocellular carcinoma. Biomedicine & Pharmacotherapy 2019; 116 doi: 10.1016/j.biopha.2019.108852
|
| 20 |
Hediyeh Sepahi Zavareh, Mehrab Pourmadadi, Ali Moradi, Fatemeh Yazdian, Meisam Omidi. Chitosan/carbon quantum dot/aptamer complex as a potential anticancer drug delivery system towards the release of 5-fluorouracil. International Journal of Biological Macromolecules 2020; 165 doi: 10.1016/j.ijbiomac.2020.09.166
|
| 21 |
Dipanwita Sengupta, Kaustav Dutta Chowdhury, Avik Sarkar, Soumosish Paul, Gobinda Chandra Sadhukhan. Berberine and S allyl cysteine mediated amelioration of DEN+CCl4 induced hepatocarcinoma. Biochimica et Biophysica Acta (BBA) - General Subjects 2014; 1840(1) doi: 10.1016/j.bbagen.2013.08.020
|
| 22 |
Jaleh Varshosaz, Maryam Farzan. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(42): 12022-12041 doi: 10.3748/wjg.v21.i42.12022
|
| 23 |
Kenward Vong, Katsunori Tanaka, Koichi Fukase. Handbook of In Vivo Chemistry in Mice. 2020; doi: 10.1002/9783527344406.ch17
|
| 24 |
Wan-Jiang Xue, Ying Feng, Fei Wang, Yi-Bing Guo, Peng Li, Lei Wang, Yi-Fei Liu, Zhi-Wei Wang, Yu-Min Yang, Qin-Sheng Mao. Asialoglycoprotein receptor-magnetic dual targeting nanoparticles for delivery of RASSF1A to hepatocellular carcinoma. Scientific Reports 2016; 6(1) doi: 10.1038/srep22149
|
| 25 |
Hao Dong, Li Tian, Meng Gao, Hong Xu, Chenghong Zhang, Li Lv, Jianbin Zhang, Changyuan Wang, Yan Tian, Xiaochi Ma. Promising galactose-decorated biodegradable poloxamer 188-PLGA diblock copolymer nanoparticles of resibufogenin for enhancing liver cancer therapy. Drug Delivery 2017; 24(1) doi: 10.1080/10717544.2017.1373165
|
| 26 |
Ahmed R. Gardouh, Bassant M. Barakat, Mona K.E. Qushawy, Amany Y. El-kazzaz, Manal M. Sami, Sawsan A. Zaitone. Antitumor activity of a molecularly imprinted nanopreparation of 5-flurouracil against Ehrlich's carcinoma solid tumors grown in mice: Comparison to free 5-flurouracil. Chemico-Biological Interactions 2018; 295 doi: 10.1016/j.cbi.2018.04.019
|
| 27 |
Hend Mohamed Anter, Reham Mokhtar Aman, Dina Ibrahim Ali Othman, Khaled M. Elamin, Irhan Ibrahim Abu Hashim, Mahasen Mohamed Meshali. Apocynin-loaded PLGA nanomedicine tailored with galactosylated chitosan intrigue asialoglycoprotein receptor in hepatic carcinoma: Prospective targeted therapy. International Journal of Pharmaceutics 2023; 631 doi: 10.1016/j.ijpharm.2022.122536
|
| 28 |
Ghasem Ghalamfarsa, Mohammad Hojjat-Farsangi, Mousa Mohammadnia-Afrouzi, Enayat Anvari, Shohreh Farhadi, Mehdi Yousefi, Farhad Jadidi-Niaragh. Application of nanomedicine for crossing the blood–brain barrier: Theranostic opportunities in multiple sclerosis. Journal of Immunotoxicology 2016; 13(5) doi: 10.3109/1547691X.2016.1159264
|
| 29 |
Wen-Ping Jiang, Jaung-Geng Lin, Atsushi Inose, Wen-Liang Wu, Song-Jie Chiang, Guan-Jhong Huang. Momordica charantia L. Confers Multifaceted Protection Against 5-Fluorouracil-Induced Intestinal Injury via Inhibition of Inflammation, Oxidative Stress, Epithelial-Mesenchymal Transition, and Tight Junction Disruption. Antioxidants 2026; 15(4) doi: 10.3390/antiox15040431
|
| 30 |
Rammohan Devulapally, Ramasamy Paulmurugan. Polymer nanoparticles for drug and small silencing RNA delivery to treat cancers of different phenotypes. WIREs Nanomedicine and Nanobiotechnology 2014; 6(1) doi: 10.1002/wnan.1242
|
| 31 |
Hadeer M. Abdelaziz, Sarah Mokhtar, Doaa M. Anwar, Sherine N. Khattab, Kadria A. Elkhodairy, Ahmed O. Elzoghby. Advanced Nanoformulations. 2023; doi: 10.1016/B978-0-323-85785-7.00017-6
|
| 32 |
Mohamed T. El-Saadony, Ahmed M. Saad, Mahmoud Sitohy, Samar Sami Alkafaas, Mthokozisi Dladla, Soumya Ghosh, Dina Mostafa Mohammed, Tarek N. Soliman, Essam H. Ibrahim, Mohamed A. Fahmy, Juwan S. AbuQamar, Khaled A. El- Tarabily. Chitosan nanoparticles: Green synthesis, biological activities, and sustainable frontiers in targeted drug delivery and cancer nanomedicine – A comprehensive review. Materials Today Bio 2025; 35 doi: 10.1016/j.mtbio.2025.102358
|
| 33 |
Durgaramani Sivadasan, Muhammad H. Sultan, Saad S. Alqahtani, Shamama Javed. Cubosomes in Drug Delivery—A Comprehensive Review on Its Structural Components, Preparation Techniques and Therapeutic Applications. Biomedicines 2023; 11(4) doi: 10.3390/biomedicines11041114
|
| 34 |
Mohamed Fawzi Kabil, Maha Nasr, Ibrahim M. El-Sherbiny. Conventional and hybrid nanoparticulate systems for the treatment of hepatocellular carcinoma: An updated review. European Journal of Pharmaceutics and Biopharmaceutics 2021; 167 doi: 10.1016/j.ejpb.2021.07.003
|
| 35 |
Mohammad Jaber MasodKhooy, Massoumeh Farasat, Mohamadreza Salehi Salmi, Hamed Mirzaei. Combinatorial treatment with Silybum marianum essential oil enhances the therapeutic efficacy of a 5‐fluorouracil base therapy for hepatocellular carcinoma. Phytotherapy Research 2023; 37(5) doi: 10.1002/ptr.7716
|
| 36 |
Fatemeh Rafieenia, Seyed Omar Ebrahimi, Ensieh sadat Emadi, Forough Taheri, Somayeh Reiisi. Bioengineered chimeric tRNA/pre‐miRNAs as prodrugs in cancer therapy. Biotechnology Progress 2023; 39(6) doi: 10.1002/btpr.3387
|
| 37 |
Hyung Joon Yim, Sang Jun Suh, Soon Ho Um. Current management of hepatocellular carcinoma: An Eastern perspective. World Journal of Gastroenterology 2015; 21(13): 3826-3842 doi: 10.3748/wjg.v21.i13.3826
|
| 38 |
Elisabete Fernandes, José Alexandre Ferreira, Peixoto Andreia, Lima Luís, Sérgio Barroso, Bruno Sarmento, Lúcio Lara Santos. New trends in guided nanotherapies for digestive cancers: A systematic review. Journal of Controlled Release 2015; 209 doi: 10.1016/j.jconrel.2015.05.003
|
| 39 |
Mi‐Sun Lim, Se‐Young Choung, Kwang Won Jeong. Germacrone Inhibits Estrogen Receptor α‐Mediated Transcription in MCF‐7 Breast Cancer Cells. Phytotherapy Research 2016; 30(12) doi: 10.1002/ptr.5711
|
| 40 |
Shital S. Panchal, Somsuvra B. Ghatak, Abhishek B. Jha, Raoul Onattu. Reduction of liver tumerogenic effect of N-nitrosodiethylamine by treatment with ɣ-oryzanol in Balb/C mice. Environmental Toxicology and Pharmacology 2017; 56 doi: 10.1016/j.etap.2017.08.006
|
| 41 |
Smita Singh, Kapil Sachan, Suryakant Verma, Nidhi Singh, Pranjal Kumar Singh. Cubosomes: An Emerging and Promising Drug Delivery System for
Enhancing Cancer Therapy. Current Pharmaceutical Biotechnology 2024; 25(6) doi: 10.2174/0113892010257937231025065352
|
| 42 |
Ahmed A. Abd-Rabou, Dhruba J. Bharali, Shaker A. Mousa. Viramidine-Loaded Galactosylated Nanoparticles Induce Hepatic Cancer Cell Apoptosis and Inhibit Angiogenesis. Applied Biochemistry and Biotechnology 2020; 190(1) doi: 10.1007/s12010-019-03090-2
|
| 43 |
Leander Corrie, Monica Gulati, Ankit Awasthi, Sukriti Vishwas, Jaskiran Kaur, Rubiya Khursheed, Omji Porwal, Aftab Alam, Shaik Rahana Parveen, Hardeep Singh, Dinesh Kumar Chellappan, Gaurav Gupta, Popat Kumbhar, John Disouza, Vandana Patravale, Jon Adams, Kamal Dua, Sachin Kumar Singh. Harnessing the dual role of polysaccharides in treating gastrointestinal diseases: As therapeutics and polymers for drug delivery. Chemico-Biological Interactions 2022; 368 doi: 10.1016/j.cbi.2022.110238
|
| 44 |
Tanushree D. Malode, Sakshi B. Pillare, Anurag K. Shahi, Swati N. Lade, Jayshree B. Taksande, Milind J. Umekar. Cubosomes as Versatile Nanocarriers: Insights into Composition, Mechanisms, and Therapeutic Applications. Biomedical Materials & Devices 2026; 4(3) doi: 10.1007/s44174-025-00416-z
|
| 45 |
Maimoona Qindeel, Naveed Ahmed, Gul Majid Khan, Asim.ur. Rehman. Ligand Decorated Chitosan as an Advanced Nanocarrier for Targeted Delivery: A Critical Review. Nanomedicine 2019; 14(12) doi: 10.2217/nnm-2018-0490
|
| 46 |
Su Bu, Xinrui Zhou, Deyi Li, Fei Lu, Xingxing Huo, Chao Tian, Chijing Zuo, Hang Song. Polysaccharides-mediated mitochondrial remodeling: role in chemotherapy resistance of gastrointestinal tumors. Phytomedicine 2026; doi: 10.1016/j.phymed.2026.158624
|
| 47 |
Ana Casadó, Maria Lluïsa Sagristá, Margarita Mora. Formulation and In Vitro Characterization of Thermosensitive Liposomes for the Delivery of Irinotecan. Journal of Pharmaceutical Sciences 2014; 103(10) doi: 10.1002/jps.24097
|
| 48 |
Neha Jaiswal, Ravindra D. Chaudhari, Bhushan P. Chaudhari. Understanding fundamentals of hepatocellular carcinoma to design next-generation chitosan nano-formulations: Beyond chemotherapy stride. Journal of Drug Delivery Science and Technology 2020; 58 doi: 10.1016/j.jddst.2020.101723
|
| 49 |
Jaung-Geng Lin, Yu-Wen Sun, Wen-Liang Wu, Wen-Ping Jiang, Fang-Yu Zhung, Guan-Jhong Huang. Multi-Target Protective Effects of Sanghuangporus sanghuang Against 5-Fluorouracil-Induced Intestinal Injury Through Suppression of Inflammation, Oxidative Stress, Epitheli-Al-Mesenchymal Transition, and Tight Junction. International Journal of Molecular Sciences 2025; 26(7) doi: 10.3390/ijms26073444
|
| 50 |
Yonglin Wan, Xiaoqing Yu, Jun Wang, Qiuyun Liu, Tingting Zhang, Xuedi Weng, Yan Shen, Xiaohong Fu. Ultrasound-responsive exosome-derived Nanovesicles for targeted taxinine delivery in hepatocellular carcinoma therapy. Journal of Drug Delivery Science and Technology 2026; 123 doi: 10.1016/j.jddst.2026.108541
|
| 51 |
A. Anitha, N. Deepa, K.P. Chennazhi, Vinoth-Kumar Lakshmanan, R. Jayakumar. Combinatorial anticancer effects of curcumin and 5-fluorouracil loaded thiolated chitosan nanoparticles towards colon cancer treatment. Biochimica et Biophysica Acta (BBA) - General Subjects 2014; 1840(9) doi: 10.1016/j.bbagen.2014.06.004
|
| 52 |
H. Y. Pan, H. Yang, M. Y. Shao, J. Xu, P. Zhang, R. Cheng, T. Hu. Sphingosine‐1‐phosphate mediates AKT/ERK maintenance of dental pulp homoeostasis. International Endodontic Journal 2015; 48(5) doi: 10.1111/iej.12335
|
| 53 |
Yu-Lan Li, Xiao-Min Zhu, Hong Liang, Chris Orvig, Zhen-Feng Chen. Recent Advances in Asialoglycoprotein Receptor and Glycyrrhetinic Acid Receptor-Mediated and/or pH-Responsive Hepatocellular Carcinoma- Targeted Drug Delivery. Current Medicinal Chemistry 2021; 28(8) doi: 10.2174/0929867327666200505085756
|
| 54 |
Maritina Rouchota, Alessio Adamiano, Michele Iafisco, Eirini Fragogeorgi, Irineos Pilatis, Gilles Doumont, Sébastien Boutry, Daniele Catalucci, Argyro Zacharioudaki, George C. Kagadis. Optimization of In Vivo Studies by Combining Planar Dynamic and Tomographic Imaging: Workflow Evaluation on a Superparamagnetic Nanoparticles System. Molecular Imaging 2021; 2021 doi: 10.1155/2021/6677847
|